Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer

Study Summary

This phase II trial studies how well trametinib works in treating patients with hormone-resistant prostate cancer that is growing or getting worse and has spread to other parts of the body. Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.